Evapotranspiration has been poorly characterized in the Altiplano, and the legal dispute over the status and use of the waters of the Silala River provided an opportunity for improving knowledge of this hydrological process, in a remote area with a lack of hydrometeorological data. Actual evapotranspiration (ETa) measurements using eddy covariance (EC) were performed in the riparian wetland (EC1) and over the alluvial deposits (EC2) of the Silala River basin, and in the Putana River wetland (EC3), with similar characteristics to the Silala River headwaters. The portable chamber method was used to characterize soil and plant evaporation near EC2. Satellite‐derived ETa estimates were evaluated with the in‐situ data, and used to investigate spatiotemporal dynamics of the wetland vegetation cover. At EC1 and EC3, annual ETa values were 703 and 841 mm, respectively; and satellite‐derived ETa showed differences of 5% and −35% from these values. ETa exhibited strong seasonal variations at EC1 and EC3, and was sensitive to precipitation at EC2. ETa did not follow the temporal evolution of the reference evapotranspiration at EC2, suggesting that lateral subsurface flow supports ETa in dry periods. Portable chamber measurements revealed that bare soil evaporation is the main component of ETa in the alluvial deposits. ETa data collected within the basin, as described in other papers of this special issue, allowed validation of a hydrological model used to estimate the basin's groundwater recharge, and estimation of the surface flow increase due to river channelization, which were important scientific evidence provided in the legal dispute.This article is categorized under:
Science of Water > Hydrological Processes
Science of Water > Methods
Atrazine is a potent endocrine disruptor that both chemically castrates and feminizes male amphibians. It depletes androgens in adult frogs and reduces androgen-dependent growth of the larynx in developing male larvae. It also disrupts normal gonadal development and feminizes the gonads of developing males. Gonadal malformations induced by atrazine include hermaphrodites and males with multiple testes [single sex polygonadism (SSP)], and effects occur at concentrations as low as 0.1 ppb (μg/L). Here, we describe the frequencies at which these malformations occur and compare them with morphologies induced by the estrogen, 17β-estradiol (E2), and the antiandrogen cyproterone acetate, as a first step in testing the hypothesis that the effects of atrazine are a combination of demasculinization and feminization. The various forms of hermaphroditism did not occur in controls. Nonpigmented ovaries, which occurred at relatively high frequencies in atrazine-treated larvae, were found in four individuals out of more than 400 controls examined (1%). Further, we show that several types of gonadal malformations (SSP and three forms of hermaphroditism) are produced by E2 exposure during gonadal differentiation, whereas a final morphology (nonpigmented ovaries) appears to be the result of chemical castration (disruption of androgen synthesis and/or activity) by atrazine. These experimental findings suggest that atrazine-induced gonadal malformations result from the depletion of androgens and production of estrogens, perhaps subsequent to the induction of aromatase by atrazine, a mechanism established in fish, amphibians, reptiles, and mammals (rodents and humans).
Serum levels of testosterone, FSH, LH and prolactin were measured by RIA in patients with BPH (benign prostatic hypertrophy) and in control men. The testosterone concentrations in the BPH group were significantly lower than that of the control group. Serum concentrations of FSH, LH, prolactin and estradiol, did not differ significantly in the 2 groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.